ADC Journey to Clinic: Outlining How Operational Strategy Supports Speed to IND
- Breaking down the complex pathway, key activities and rate-determining steps to advance ADCs from candidate selection to first-in-human clinical trials
- Sharing strategies used to ensure timely production of ADC toxicology material and readiness for GMP manufacture
- Contextualizing approaches and learnings to promote speed and success in ADC development and technology transfer